This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Helen Kotanides: Innovator in Antibody Development
Introduction
Helen Kotanides is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Helen holds a patent for "Humanized anti-CD45 antibodies." This patent includes humanized anti-human CD45 antibodies and pharmaceutical compositions that incorporate these antibodies. Her innovative approach in this area showcases her expertise and commitment to advancing medical science.
Career Highlights
Helen is currently associated with Actinium Pharmaceuticals, Limited, where she continues to work on groundbreaking research and development projects. Her role at the company allows her to collaborate with other experts in the field and contribute to the advancement of antibody therapies.
Collaborations
Helen has worked alongside her coworker, Lequn Zhao, to further enhance the research and development of antibody-based treatments. Their collaboration exemplifies the importance of teamwork in scientific innovation.
Conclusion
Helen Kotanides is a dedicated inventor whose work in humanized antibodies is paving the way for new therapeutic options. Her contributions to Actinium Pharmaceuticals and the field of biotechnology highlight her role as a key innovator in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile